Genomics and Proteomics in Predicting Cancer Outcomes

Alexander A. Parikh, J. Chad Johnson, Nipun Merchant

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Sequencing of the human genome and the acquisition of genomic data combined with advances in genomic and proteomic technologies have fueled a revolution in understanding disease. The combination of genomics and proteomics has provided a unique opportunity to diagnose, classify, and detect malignant disease, to better understand and define the behavior of specific tumors, and to provide direct and targeted therapy. Nevertheless, challenges remain, including integration and standardization of techniques and validation against accepted clinical and pathologic parameters. This article provides a summary of technologies, potential clinical applications, and challenges.

Original languageEnglish (US)
Pages (from-to)257-277
Number of pages21
JournalSurgical Oncology Clinics of North America
Volume17
Issue number2
DOIs
StatePublished - Apr 2008
Externally publishedYes

Fingerprint

Genomics
Proteomics
Technology
Human Genome
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Genomics and Proteomics in Predicting Cancer Outcomes. / Parikh, Alexander A.; Johnson, J. Chad; Merchant, Nipun.

In: Surgical Oncology Clinics of North America, Vol. 17, No. 2, 04.2008, p. 257-277.

Research output: Contribution to journalArticle

Parikh, Alexander A. ; Johnson, J. Chad ; Merchant, Nipun. / Genomics and Proteomics in Predicting Cancer Outcomes. In: Surgical Oncology Clinics of North America. 2008 ; Vol. 17, No. 2. pp. 257-277.
@article{aeac9b8991d74844aa31ee46336e7f2f,
title = "Genomics and Proteomics in Predicting Cancer Outcomes",
abstract = "Sequencing of the human genome and the acquisition of genomic data combined with advances in genomic and proteomic technologies have fueled a revolution in understanding disease. The combination of genomics and proteomics has provided a unique opportunity to diagnose, classify, and detect malignant disease, to better understand and define the behavior of specific tumors, and to provide direct and targeted therapy. Nevertheless, challenges remain, including integration and standardization of techniques and validation against accepted clinical and pathologic parameters. This article provides a summary of technologies, potential clinical applications, and challenges.",
author = "Parikh, {Alexander A.} and Johnson, {J. Chad} and Nipun Merchant",
year = "2008",
month = "4",
doi = "10.1016/j.soc.2007.12.001",
language = "English (US)",
volume = "17",
pages = "257--277",
journal = "Surgical Oncology Clinics of North America",
issn = "1055-3207",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Genomics and Proteomics in Predicting Cancer Outcomes

AU - Parikh, Alexander A.

AU - Johnson, J. Chad

AU - Merchant, Nipun

PY - 2008/4

Y1 - 2008/4

N2 - Sequencing of the human genome and the acquisition of genomic data combined with advances in genomic and proteomic technologies have fueled a revolution in understanding disease. The combination of genomics and proteomics has provided a unique opportunity to diagnose, classify, and detect malignant disease, to better understand and define the behavior of specific tumors, and to provide direct and targeted therapy. Nevertheless, challenges remain, including integration and standardization of techniques and validation against accepted clinical and pathologic parameters. This article provides a summary of technologies, potential clinical applications, and challenges.

AB - Sequencing of the human genome and the acquisition of genomic data combined with advances in genomic and proteomic technologies have fueled a revolution in understanding disease. The combination of genomics and proteomics has provided a unique opportunity to diagnose, classify, and detect malignant disease, to better understand and define the behavior of specific tumors, and to provide direct and targeted therapy. Nevertheless, challenges remain, including integration and standardization of techniques and validation against accepted clinical and pathologic parameters. This article provides a summary of technologies, potential clinical applications, and challenges.

UR - http://www.scopus.com/inward/record.url?scp=41049084986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41049084986&partnerID=8YFLogxK

U2 - 10.1016/j.soc.2007.12.001

DO - 10.1016/j.soc.2007.12.001

M3 - Article

C2 - 18375352

AN - SCOPUS:41049084986

VL - 17

SP - 257

EP - 277

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

SN - 1055-3207

IS - 2

ER -